Published in J Int AIDS Soc on January 11, 2013
Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010). PLoS One (2014) 0.93
Predictors of medication adherence among HIV-positive women in North America. J Obstet Gynecol Neonatal Nurs (2014) 0.89
Addressing gender inequalities to improve the sexual and reproductive health and wellbeing of women living with HIV. J Int AIDS Soc (2015) 0.87
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study. PLoS One (2013) 0.86
The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada. J Int AIDS Soc (2015) 0.82
Women hold up half the sky - and half the burden of the HIV epidemic. J Int AIDS Soc (2013) 0.77
The impact of criminalization of HIV non-disclosure on the healthcare engagement of women living with HIV in Canada: a comprehensive review of the evidence. J Int AIDS Soc (2015) 0.76
Intrapartum care of the HIV-positive woman. CMAJ (2013) 0.75
Examining Privacy Regulatory Frameworks in Canada in the Context of HIV. Healthc Policy (2016) 0.75
Sexual and reproductive health and human rights of women living with HIV. J Int AIDS Soc (2015) 0.75
Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada. PLoS One (2017) 0.75
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA (1999) 10.93
Barriers to use of free antiretroviral therapy in injection drug users. JAMA (1998) 6.67
The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence. Stud Fam Plann (2001) 3.73
HIV/AIDS in women: an expanding epidemic. Science (2005) 3.68
Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. AIDS (2006) 3.17
Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS (2006) 3.02
How men's power over women fuels the HIV epidemic. BMJ (2002) 2.55
Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse (2003) 2.54
Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health (2004) 2.50
HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med (2005) 2.40
The 2007 Estimates for People at Risk for and Living With HIV in China: Progress and Challenges. J Acquir Immune Defic Syndr (2009) 2.27
Gender, sexuality, and HIV/AIDS: the what, the why, and the how. Can HIV AIDS Policy Law Rev (2000) 2.21
The social context of women's health: goals and objectives for medical education. CMAJ (1995) 2.17
HIV-infected parents and their children in the United States. Am J Public Health (2000) 2.13
Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care (2005) 2.12
Intimate partner violence and HIV risk among urban minority women in primary health care settings. AIDS Behav (2003) 2.06
Beyond the male condom: the evolution of gender-specific HIV interventions for women. Annu Rev Sex Res (2003) 2.03
Stigma: a health barrier for women with HIV/AIDS. J Assoc Nurses AIDS Care (2004) 1.93
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother (2007) 1.89
From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs (2008) 1.83
Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis (2003) 1.77
Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care (2003) 1.69
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr (2000) 1.67
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS (2005) 1.55
Delays in seeking HIV care due to competing caregiver responsibilities. Am J Public Health (2000) 1.53
Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep (2011) 1.50
Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care (2010) 1.44
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr (2003) 1.44
Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med Care (1995) 1.43
Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS (2005) 1.42
Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS (2007) 1.40
Perceived barriers to HIV care among HIV-infected women in the Deep South. J Assoc Nurses AIDS Care (2010) 1.38
Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside. J Urban Health (2005) 1.35
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort. HIV Med (2010) 1.29
Characteristics of women-only and mixed-gender drug abuse treatment programs. J Subst Abuse Treat (1999) 1.21
Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis (2011) 1.20
Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS (2009) 1.19
The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence: a conundrum for methadone maintenance treatment. Mt Sinai J Med (2000) 1.17
Preventing sexual transmission of HIV. Clin Infect Dis (2007) 1.16
Domestic violence in barriers to health care for HIV-positive women. AIDS Patient Care STDS (2006) 1.15
Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival. Arch Intern Med (2000) 1.14
Better mind the gap: addressing the shortage of HIV-positive women in clinical trials. AIDS (2010) 1.14
Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol (2012) 1.09
Women and HIV/AIDS in China: gender and vulnerability. Health Care Women Int (2007) 1.02
Does gender-specific substance abuse treatment for women promote continuity of care? J Subst Abuse Treat (2006) 1.02
Barriers to health-seeking behaviors for women infected with HIV. Nursingconnections (1996) 0.99
Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohort. J Acquir Immune Defic Syndr (2004) 0.99
Transformative combinations: women's health and human rights. J Am Med Womens Assoc (1997) 0.98
Diffusion of innovation in women's health care delivery: the Department of Veterans Affairs' adoption of women's health clinics. Womens Health Issues (2006) 0.97
Gender, sex, and HIV: how well are we addressing the imbalance? Curr Opin HIV AIDS (2008) 0.93
Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial. J Acquir Immune Defic Syndr (2005) 0.92
Maternal mental health and integrated programs for mothers with substance abuse issues. Psychol Addict Behav (2010) 0.91
Integrating mental health services into primary HIV care for women: the Whole Life project. Public Health Rep (2004) 0.87
Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat (2008) 0.86
Sustained HIV viral suppression following treatment interruption: an observational study. AIDS Res Hum Retroviruses (2006) 0.85
Stigma, discrimination, and sexual (dis)satisfaction among people living with HIV: results from the "AIDES et toi" survey. AIDS Care (2010) 0.84
Meeting the needs of women living with HIV. Public Health Nurs (1998) 0.84
The challenges of seeking and receiving support for women living with HIV. Health Commun (2010) 0.83
Gynecologic issues in the HIV-infected woman. Infect Dis Clin North Am (2008) 0.83
Working women's sexual risk taking in Jamaica. Soc Sci Med (1996) 0.83
Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme. Antivir Ther (2003) 0.82
Commercial sex work and STD: the need for policy interventions to change societal patterns. Sex Transm Dis (1998) 0.81
Gender-sensitive mental health care. Australas Psychiatry (2009) 0.81
Illuminating social determinants of women's health using grounded theory. Health Care Women Int (2002) 0.81
Women-focused treatment agencies and process improvement: Strategies to increase client engagement. Women Ther (2009) 0.80
Women and human immunodeficiency virus: unique management issues. Am J Med Sci (2004) 0.80
Women's experiences accessing a women-centered cardiac rehabilitation program: a qualitative study. J Cardiovasc Nurs (2010) 0.78
Family-friendly HIV and AIDS care the goal at Vancouver's Oak Tree Clinic. CMAJ (1996) 0.77
AIDS: the development of a gender appropriate research intervention. Soc Work Health Care (2000) 0.77
Changes in treatment content of services during trauma-informed integrated services for women with co-occurring disorders. Community Ment Health J (2009) 0.76
The profile of HIV infection in women: a challenge to the profession. Soc Work Health Care (1997) 0.76
Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med (2008) 7.33
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med (2008) 5.58
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2014) 2.79
Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda. AIDS Behav (2008) 2.53
Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation. Clin Infect Dis (2013) 2.31
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. Clin Infect Dis (2010) 2.14
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One (2012) 2.02
Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. J Infect Dis (2012) 2.00
HIV, gender, race, sexual orientation, and sex work: a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada. PLoS Med (2011) 1.85
Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One (2013) 1.79
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. Lancet Infect Dis (2013) 1.78
Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. Am J Public Health (2008) 1.77
Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens. AIDS (2008) 1.55
Reproductive decision-making and periconception practices among HIV-positive men and women attending HIV services in Durban, South Africa. AIDS Behav (2013) 1.50
Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep (2011) 1.50
A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks. J Acquir Immune Defic Syndr (2009) 1.49
HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis. Sex Transm Dis (2008) 1.49
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol (2007) 1.45
Associations between HIV-related stigma, racial discrimination, gender discrimination, and depression among HIV-positive African, Caribbean, and Black women in Ontario, Canada. AIDS Patient Care STDS (2013) 1.42
Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection. PLoS One (2011) 1.32
Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Arch Intern Med (2010) 1.30
Conversations with mothers: exploring reasons for prevention of mother-to-child transmission (PMTCT) failures in the era of programmatic scale-up in Soweto, South Africa. AIDS Behav (2012) 1.26
Severe acute respiratory syndrome. Clin Infect Dis (2004) 1.23
"We don't exist": a qualitative study of marginalization experienced by HIV-positive lesbian, bisexual, queer and transgender women in Toronto, Canada. J Int AIDS Soc (2012) 1.22
Sex worker-led structural interventions in India: a case study on addressing violence in HIV prevention through the Ashodaya Samithi collective in Mysore. Indian J Med Res (2012) 1.22
Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol (2007) 1.20
Lost opportunities to reduce periconception HIV transmission: safer conception counseling by South African providers addresses perinatal but not sexual HIV transmission. J Acquir Immune Defic Syndr (2014) 1.15
Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol (2011) 1.15
Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One (2013) 1.08
A conceptual framework for understanding HIV risk behavior in the context of supporting fertility goals among HIV-serodiscordant couples. Reprod Health Matters (2012) 1.07
Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases. Antivir Ther (2010) 1.06
Correlates of HIV stigma in HIV-positive women. Arch Womens Ment Health (2010) 1.05
Responding to her question: a review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in sub-Saharan Africa. AIDS Behav (2009) 1.02
HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS (2013) 1.02
Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study. BMC Med Res Methodol (2013) 1.01
Social determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study. Open Med (2011) 0.98
Direct and indirect effects of perceived social support on health-related quality of life in persons living with HIV/AIDS. AIDS Care (2012) 0.97
Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav (2011) 0.97
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada. HIV Clin Trials (2011) 0.96
HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr (2016) 0.94
The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. Cad Saude Publica (2007) 0.93
Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther (2014) 0.92
HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy. AIDS (2013) 0.91
Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020. AIDS Res Ther (2011) 0.91
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries. BMC Infect Dis (2010) 0.91
Factors associated with disclosure of HIV status among a cohort of individuals on antiretroviral therapy in British Columbia, Canada. AIDS Behav (2014) 0.91
Breaking the Glass Ceiling: Increasing the Meaningful Involvement of Women Living With HIV/AIDS (MIWA) in the Design and Delivery of HIV/AIDS Services. Health Care Women Int (2014) 0.90
Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada. J Int Assoc Physicians AIDS Care (Chic) (2012) 0.90
Canadian HIV Pregnancy Planning Guidelines: No. 278, June 2012. Int J Gynaecol Obstet (2012) 0.90
Environmental scan of anal cancer screening practices: worldwide survey results. Cancer Med (2014) 0.90
Predictors of gonorrhea reinfection in a cohort of sexually transmitted disease patients in Alberta, Canada, 1991-2003. Sex Transm Dis (2007) 0.89
Opportunities, ethical challenges, and lessons learned from working with peer research assistants in a multi-method HIV community-based research study in Ontario, Canada. J Empir Res Hum Res Ethics (2012) 0.89
Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy. HIV Clin Trials (2011) 0.88
Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sex Health (2012) 0.88
Correlates of anxiety in women living with HIV of reproductive age. AIDS Behav (2012) 0.87
Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know? J Acquir Immune Defic Syndr (2014) 0.87
Cohort Profile: Longitudinal Investigations into Supportive and Ancillary health services. Int J Epidemiol (2012) 0.87
Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa. AIDS Behav (2009) 0.87
Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed. AIDS Behav (2011) 0.87
A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164). J Acquir Immune Defic Syndr (2007) 0.86
Identifying self-perceived HIV-related stigma in a population accessing antiretroviral therapy. AIDS Care (2012) 0.86
"Hear(ing) New Voices": Peer Reflections from Community-Based Survey Development with Women Living with HIV. Prog Community Health Partnersh (2015) 0.86
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy. J Acquir Immune Defic Syndr (2011) 0.85
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption. BMC Infect Dis (2008) 0.85
Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study. Reprod Health (2010) 0.85
Factors affecting banking quality of umbilical cord blood for transplantation. Transfusion (2010) 0.85
A review of reproductive health research, guidelines and related gaps for women living with HIV. AIDS Care (2012) 0.85
HAART slows progression to anal cancer in HIV-infected MSM. AIDS (2015) 0.85
Establishing the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study. BMC Med Res Methodol (2016) 0.84
Towards an HIV-free generation: getting to zero or getting to rights? Reprod Health Matters (2012) 0.84
The epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African-Caribbean women in Toronto. BMC Infect Dis (2013) 0.84
Physician attitudes regarding pregnancy, fertility care, and assisted reproductive technologies for HIV-infected individuals and couples. HIV Clin Trials (2012) 0.84
Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial. AIDS (2012) 0.84
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids. Antivir Ther (2005) 0.84
Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. AIDS (2014) 0.83
Inclusion body myositis: another possible manifestation of antiretroviral-associated mitochondrial toxicity. AIDS (2003) 0.83
Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis. AIDS (2013) 0.83
Sustainability of an HIV PEP Program for Sexual Assault Survivors: "Lessons Learned" from Health Care Providers. Open AIDS J (2011) 0.83
Socio-economic- and sex-related disparities in rates of hospital admission among patients with HIV infection in Ontario: a population-based study. Open Med (2012) 0.82
Pharmacokinetics of maraviroc, raltegravir, darunavir, and etravirine in the semen of HIV-infected men. J Acquir Immune Defic Syndr (2013) 0.82
Sexual inactivity and sexual satisfaction among women living with HIV in Canada in the context of growing social, legal and public health surveillance. J Int AIDS Soc (2015) 0.82
HIV protease inhibitors in pregnancy : pharmacology and clinical use. Drugs (2013) 0.81
Severe acute respiratory syndrome: quantitative assessment from chest radiographs with clinical and prognostic correlation. AJR Am J Roentgenol (2005) 0.81
Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection. J Acquir Immune Defic Syndr (2008) 0.81